Andrea L. Richardson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrea L. Richardson has a total of 196 co-authors. Here are the top co-authors by number of shared publications:
April Greene-Colozzi
20 shared publicationsHanna S. Kuznetsov
18 shared publications- Sandra S. McAllister
Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Boston, USA
18 shared publications - Timothy Marsh
Hematology Division, Brigham & Women's Hospital, Boston, MA 02115, USA
18 shared publications Zafira Castaño
18 shared publicationsBeth A. Markens
9 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Springer Nature in npj Breast Cancer
Nucleotide excision repair deficiency identified by mutational signatures is associated with cisplatin response in triple-negative breast cancer
- 12 November 2026
- Published by Springer Nature in npj Breast Cancer
Open AccessNucleotide excision repair deficiency identified by mutational signatures is associated with cisplatin response in triple-negative breast cancer
- Open Access
- 22 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Patient-derived separation-of-function mutations reveal specific role for BRCA1 coiled coil domain in genome stability
Specific inherited mutations of BRCA1 compromise homologous recombination repair and increase the risk of cancer. Here, we employ a panel of isogenic chicken DT40 cell lines for the comparative study of the main BRCA1 protein domains and of common BRCA1 founder mutations in genome stability and DNA repair. Whole genome sequencing of cell clones demonstrates that the L1407P-equivalent coiled coil domain variant is a separation-of-function mutant with an increased rate of base substitution mutagenesis but not of deletions or large-scale genomic instability, reflecting its proficiency in repairing DNA double strand breaks and promoting sister chromatid exchanges. The BRCA1 coiled coil domain mediates interaction with PALB2, and PALB2 coiled coil domain mutations also primarily affect base substitution mutagenesis. In contrast, truncating and missense mutations in the RING and BRCT domains affect all functions of BRCA1, inducing larger deletions and rearrangements typical of BRCA1 loss. PARP inhibitor sensitivity is marginal in the coiled coil domain mutants, instead it correlates with deletion mutagenesis, degradation of stalled replication forks, and impaired RAD51 loading following topoisomerase I inhibition. Our results suggest a specific function for the BRCA1-PALB2 interaction in promoting error-free DNA damage bypass as an alternative to mutagenic translesion DNA synthesis.
- 22 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessPatient-derived separation-of-function mutations reveal specific role for BRCA1 coiled coil domain in genome stability
Specific inherited mutations of BRCA1 compromise homologous recombination repair and increase the risk of cancer. Here, we employ a panel of isogenic chicken DT40 cell lines for the comparative study of the main BRCA1 protein domains and of common BRCA1 founder mutations in genome stability and DNA repair. Whole genome sequencing of cell clones demonstrates that the L1407P-equivalent coiled coil domain variant is a separation-of-function mutant with an increased rate of base substitution mutagenesis but not of deletions or large-scale genomic instability, reflecting its proficiency in repairing DNA double strand breaks and promoting sister chromatid exchanges. The BRCA1 coiled coil domain mediates interaction with PALB2, and PALB2 coiled coil domain mutations also primarily affect base substitution mutagenesis. In contrast, truncating and missense mutations in the RING and BRCT domains affect all functions of BRCA1, inducing larger deletions and rearrangements typical of BRCA1 loss. PARP inhibitor sensitivity is marginal in the coiled coil domain mutants, instead it correlates with deletion mutagenesis, degradation of stalled replication forks, and impaired RAD51 loading following topoisomerase I inhibition. Our results suggest a specific function for the BRCA1-PALB2 interaction in promoting error-free DNA damage bypass as an alternative to mutagenic translesion DNA synthesis.
- Open Access
- 17 January 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Long-term exposure to the ethanol-derived metabolite acetaldehyde elevates structural genomic alterations but not base substitutions
Acetaldehyde is the primary metabolite of ethanol, and routes of exposure include endogenous sources, food and cigarette smoke. To explore whether the mutagenic effect of acetaldehyde is responsible for the carcinogenicity of ethanol, we use whole genome sequencing on four human cell lines subjected to long-term, physiologically relevant, analytically validated acetaldehyde treatments. Unexpectedly, the treatments do not induce increased base substitution and short insertion/deletion mutagenesis, nor the appearance of the alcohol-associated cancer mutation signature SBS16. In contrast, we observe large genomic alterations in most cell lines, which parallel the association of 32 kb to 1 Mb deletions and duplications with alcohol consumption in a Japanese gastric cancer cohort. Observations of DNA damage response and a specific requirement for the homologous recombination pathway to tolerate acetaldehyde suggest that DNA breaks are responsible for structural genomic alterations in both cell line and tumour samples, and these may contribute to the carcinogenic effect of acetaldehyde.
- 17 January 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessLong-term exposure to the ethanol-derived metabolite acetaldehyde elevates structural genomic alterations but not base substitutions
Acetaldehyde is the primary metabolite of ethanol, and routes of exposure include endogenous sources, food and cigarette smoke. To explore whether the mutagenic effect of acetaldehyde is responsible for the carcinogenicity of ethanol, we use whole genome sequencing on four human cell lines subjected to long-term, physiologically relevant, analytically validated acetaldehyde treatments. Unexpectedly, the treatments do not induce increased base substitution and short insertion/deletion mutagenesis, nor the appearance of the alcohol-associated cancer mutation signature SBS16. In contrast, we observe large genomic alterations in most cell lines, which parallel the association of 32 kb to 1 Mb deletions and duplications with alcohol consumption in a Japanese gastric cancer cohort. Observations of DNA damage response and a specific requirement for the homologous recombination pathway to tolerate acetaldehyde suggest that DNA breaks are responsible for structural genomic alterations in both cell line and tumour samples, and these may contribute to the carcinogenic effect of acetaldehyde.
- Open Access
- 24 January 2025
- Published by Springer Nature in npj Breast Cancer
- Vol. 11 (1) , 1-13
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes
Special histologic subtypes of breast cancer (BC) exhibit unique phenotypes and molecular profiles with diagnostic and therapeutic implications, often differing in behavior and clinical trajectory from common BC forms. Novel methodologies, such as artificial intelligence may improve classification. Genetic predisposition plays roles in a subset of cases. Uncommon BC presentations like male, inflammatory and pregnancy-related BC pose challenges. Emerging therapeutic strategies targeting genetic alterations or immune microenvironment are being explored.
- 24 January 2025
- Published by Springer Nature in npj Breast Cancer
- Vol. 11 (1) , 1-13
Open AccessUnraveling complexity and leveraging opportunities in uncommon breast cancer subtypes
Special histologic subtypes of breast cancer (BC) exhibit unique phenotypes and molecular profiles with diagnostic and therapeutic implications, often differing in behavior and clinical trajectory from common BC forms. Novel methodologies, such as artificial intelligence may improve classification. Genetic predisposition plays roles in a subset of cases. Uncommon BC presentations like male, inflammatory and pregnancy-related BC pose challenges. Emerging therapeutic strategies targeting genetic alterations or immune microenvironment are being explored.
- Open Access
- 22 July 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (10) , 108554
Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review
- 22 July 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (10) , 108554
Open AccessExploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review
- Open Access
- 27 July 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (8) , 112887
Spontaneous mutagenesis in human cells is controlled by REV1-Polymerase ζ and PRIMPOL
- 27 July 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (8) , 112887
Open AccessSpontaneous mutagenesis in human cells is controlled by REV1-Polymerase ζ and PRIMPOL